Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
Porfirio Sanchez received a six-month jail term Friday for the 2023 deaths of Christian and Michelle Deaton in a crash ...
Columnist Teri Sforza writes that childhood obesity in California is on the rise, state data shows. Free school meals have ...
While gastrointestinal side effects like nausea and vomiting are well-documented with semaglutide, the active ingredient in Ozempic, these new reports suggest a potential link between the drug and ...
Ozempic (semaglutide) is a subcutaneous injection used in people with type 2 diabetes. It may cause mild side effects, such as abdominal pain, or more serious side effects, such as diabetic ...
Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...
Danish biopharma giant Novo Nordisk (NOV: N) is breaking new ground with its GLP-1 agonist semaglutide, as a small mid-stage ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
This means a very thin needle is inserted into the layer of fatty tissue just under the skin. Brand-name semaglutide (Wegovy and Ozempic) comes in a prefilled injection pen. This pen is single-use ...
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results